Medical History Mysteries: CBD, delta-8, and dentistry

April 20, 2022

Drs. Pamela Maragliano-Muniz and Tom Viola discuss what you need to know about CBD (cannabidiol) and delta-8 (tetrahydrocannabinol), and the risks these drugs pose for your dental patients.

Pamela Maragliano-Muniz, DMD

Tom Viola, RPh, CCP

In Medical History Mysteries, we've talked about street drugs. Now, what about CBD and delta-8?

Join us as we focus on how cannabidiol (CBD) is used, how it’s different from cannabis, how the various forms of CBD work, and how delta-8 (tetrahydrocannabinol) fits in. We’ll discuss what you need to know as a dental professional and the risks these drugs pose for your patients.

More Medical History Mysteries videos:

Editor’s note: This article first appeared in Through the Loupes newsletter, a publication of the Endeavor Business Media Dental Group. Read more articles and subscribe to Through the Loupes.

About the Author

Pamela Maragliano-Muniz, DMD

Pamela Maragliano-Muniz, DMD, is the chief editor of DentistryIQ and editorial co-director of Through the Loupes. Based in Salem, Massachusetts, Dr. Maragliano-Muniz began her clinical career as a dental hygienist. She went on to attend Tufts University School of Dental Medicine, where she earned her doctorate in dental medicine. She then attended the University of California, Los Angeles, School of Dental Medicine, where she became board-certified in prosthodontics. Dr. Maragliano-Muniz owns a private practice, Salem Dental Arts, and lectures on a variety of clinical topics. You may contact her at [email protected].

About the Author

Tom Viola, RPh, CCP

With more than 30 years’ experience as a board-certified pharmacist, clinical educator, professional speaker, and published author, Tom Viola, RPh, CCP, has earned the reputation as the go-to specialist for making pharmacology practical and useful for dental teams. He is the founder of Pharmacology Declassified and is a member of the faculty of more than 10 dental professional degree programs. Viola has contributed to several professional journals and pharmacology textbooks, and currently serves as a consultant to the American Dental Association’s Council on Scientific Affairs.